Trial intelligence / Profile preview

Preoperative Tapentadol for Analgesia in Breast Conservative Surgery

NCT07320781Completed

Sponsor
Shaukat Khanum Memorial Cancer Hospital & Research Centre
Start
Nov 2024
Primary completion
Sep 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in postoperative pain comparing Tapentadol with Placebo (2 arms). Primary endpoint: Intraoperative and postoperative morphine consumption at 4 hours. Started Nov 2024; status: completed.

02

Drugs

tapentadol
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT07320781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07320781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call